Genesis Healthcare Inc. (NYSE:GEN) shares rose 1.9% during mid-day trading on Monday . The company traded as high as $2.26 and last traded at $2.15, with a volume of 92,943 shares trading hands. The stock had previously closed at $2.11.

GEN has been the subject of a number of recent research reports. Stephens cut shares of Genesis Healthcare from an “overweight” rating to a “hold” rating in a research report on Wednesday, May 11th. Royal Bank Of Canada lowered their price target on shares of Genesis Healthcare from $5.00 to $3.00 and set an “outperform” rating for the company in a research report on Monday, May 16th. Finally, Bank of America Corp. cut shares of Genesis Healthcare from a “neutral” rating to an “underperform” rating in a report on Monday, May 16th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $4.40.

The stock has a 50-day moving average of $1.76 and a 200 day moving average of $2.16. The stock’s market capitalization is $343.96 million.

Genesis Healthcare (NYSE:GEN) last announced its earnings results on Monday, May 9th. The company reported ($0.01) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by $0.04. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company posted $0.07 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Equities analysts predict that Genesis Healthcare Inc. will post ($0.01) EPS for the current fiscal year.

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: long-term care (LTC), which includes the operation of skilled nursing facilities and assisted living facilities; therapy services, which includes its integrated and third-party rehabilitation therapy services, and hospice and home health services, which includes its hospice and home health businesses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.